These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 9103418

  • 1. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.
    Christianson SW, Greiner DL, Hesselton RA, Leif JH, Wagar EJ, Schweitzer IB, Rajan TV, Gott B, Roopenian DC, Shultz LD.
    J Immunol; 1997 Apr 15; 158(8):3578-86. PubMed ID: 9103418
    [Abstract] [Full Text] [Related]

  • 2. NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment.
    Shultz LD, Banuelos S, Lyons B, Samuels R, Burzenski L, Gott B, Lang P, Leif J, Appel M, Rossini A, Greiner DL.
    Transplantation; 2003 Oct 15; 76(7):1036-42. PubMed ID: 14557749
    [Abstract] [Full Text] [Related]

  • 3. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
    Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL.
    J Immunol; 1995 Jan 01; 154(1):180-91. PubMed ID: 7995938
    [Abstract] [Full Text] [Related]

  • 4. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients.
    Lowry PA, Shultz LD, Greiner DL, Hesselton RM, Kittler EL, Tiarks CY, Rao SS, Reilly J, Leif JH, Ramshaw H, Stewart FM, Quesenberry PJ.
    Biol Blood Marrow Transplant; 1996 Feb 01; 2(1):15-23. PubMed ID: 9078350
    [Abstract] [Full Text] [Related]

  • 5. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.
    Greiner DL, Shultz LD, Yates J, Appel MC, Perdrizet G, Hesselton RM, Schweitzer I, Beamer WG, Shultz KL, Pelsue SC.
    Am J Pathol; 1995 Apr 01; 146(4):888-902. PubMed ID: 7717456
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H, Ueda T, Kawahata M, Kobayashi K, Ebihara Y, Manabe A, Tanaka R, Ito M, Asano S, Nakahata T, Tsuji K.
    Bone Marrow Transplant; 2000 Dec 01; 26(11):1211-6. PubMed ID: 11149733
    [Abstract] [Full Text] [Related]

  • 8. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/beta2-microglobulin(null) mice.
    Kawano N, Ishikawa F, Shimoda K, Yasukawa M, Nagafuji K, Miyamoto T, Baba E, Tanaka T, Yamasaki S, Gondo H, Otsuka T, Ohshima K, Shultz LD, Akashi K, Harada M.
    Leukemia; 2005 Aug 01; 19(8):1384-90. PubMed ID: 15959532
    [Abstract] [Full Text] [Related]

  • 9. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent.
    Serreze DV, Chapman HD, Varnum DS, Gerling I, Leiter EH, Shultz LD.
    J Immunol; 1997 Apr 15; 158(8):3978-86. PubMed ID: 9103469
    [Abstract] [Full Text] [Related]

  • 10. Host NK cells are required for the growth of the human filarial parasite Brugia malayi in mice.
    Babu S, Porte P, Klei TR, Shultz LD, Rajan TV.
    J Immunol; 1998 Aug 01; 161(3):1428-32. PubMed ID: 9686607
    [Abstract] [Full Text] [Related]

  • 11. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
    Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T.
    Blood; 2002 Nov 01; 100(9):3175-82. PubMed ID: 12384415
    [Abstract] [Full Text] [Related]

  • 12. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ, Shpall EJ, McNiece I, Keller G.
    Biol Blood Marrow Transplant; 1997 Nov 01; 3(5):236-46. PubMed ID: 9450918
    [Abstract] [Full Text] [Related]

  • 13. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
    Mora C, Wong FS, Chang CH, Flavell RA.
    J Immunol; 1999 Apr 15; 162(8):4576-88. PubMed ID: 10201997
    [Abstract] [Full Text] [Related]

  • 14. An assay for human hematopoietic stem cells based on transplantation into nonobese diabetic recombination activating gene-null perforin-null mice.
    Minamiguchi H, Wingard JR, Laver JH, Mainali ES, Shultz LD, Ogawa M.
    Biol Blood Marrow Transplant; 2005 Jul 15; 11(7):487-94. PubMed ID: 15983548
    [Abstract] [Full Text] [Related]

  • 15. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
    Christianson SW, Greiner DL, Schweitzer IB, Gott B, Beamer GL, Schweitzer PA, Hesselton RM, Shultz LD.
    Cell Immunol; 1996 Aug 01; 171(2):186-99. PubMed ID: 8806787
    [Abstract] [Full Text] [Related]

  • 16. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.
    Shultz LD, Lang PA, Christianson SW, Gott B, Lyons B, Umeda S, Leiter E, Hesselton R, Wagar EJ, Leif JH, Kollet O, Lapidot T, Greiner DL.
    J Immunol; 2000 Mar 01; 164(5):2496-507. PubMed ID: 10679087
    [Abstract] [Full Text] [Related]

  • 17. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
    Wagar EJ, Cromwell MA, Shultz LD, Woda BA, Sullivan JL, Hesselton RM, Greiner DL.
    J Immunol; 2000 Jul 01; 165(1):518-27. PubMed ID: 10861091
    [Abstract] [Full Text] [Related]

  • 18. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.
    Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner DL, Handgretinger R.
    J Immunol; 2005 May 15; 174(10):6477-89. PubMed ID: 15879151
    [Abstract] [Full Text] [Related]

  • 19. Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice.
    Flavell DJ, Warnes SL, Noss AL, Flavell SU.
    Br J Cancer; 2000 Dec 15; 83(12):1755-61. PubMed ID: 11104577
    [Abstract] [Full Text] [Related]

  • 20. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
    King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL.
    Clin Immunol; 2008 Mar 15; 126(3):303-14. PubMed ID: 18096436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.